Such expression profile supports the observed shift towards the “muscle-type” LDH in malignant tumors, evident as a higher prevalence of LDH3 and LDH4 and lower prevalence of LDH1 and LDH2 isozymes, which is mostly in accordance with available data for human breast cancer samples and corresponding breast cancer cell lines [14]. The gene discussed is LDHC; the disease is cancer.